首页> 外国专利> Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes

Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes

机译:针对核原癌基因的反义化合物抑制细胞外基质合成

摘要

A method and compounds are provided for inhibiting the synthesis of extracellular matrix proteins. Compounds of the invention comprise antisense oligonucleotides specific for nuclear proto-oncogenes. Preferably, antisense compounds of the invention are selected from the group consisting of c-myc and c-myb and are locally administered. The invention finds use in the treatment of a variety of disorders, including sclerotic disorders and restenosis, associated with the inappropriate synthesis of extracellular matrix proteins, particularly collagen.
机译:提供了一种抑制细胞外基质蛋白合成的方法和化合物。本发明的化合物包含对核原癌基因具有特异性的反义寡核苷酸。优选地,本发明的反义化合物选自c-myc和c-myb,并且是局部给药的。本发明可用于治疗与细胞外基质蛋白,特别是胶原蛋白的不适当合成有关的多种疾病,包括硬化性疾病和再狭窄。

著录项

  • 公开/公告号US6133242A

    专利类型

  • 公开/公告日2000-10-17

    原文格式PDF

  • 申请/专利权人 THOMAS JEFFERSON UNIVERISITY;

    申请/专利号US19950461366

  • 发明设计人 ANDREW ZALEWSKI;YI SHI;

    申请日1995-06-05

  • 分类号A61K48/00;C07H21/04;C07H21/02;C12Q1/68;

  • 国家 US

  • 入库时间 2022-08-22 01:35:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号